El Gaaied AB - Search Results

1

Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.

Rouissi K, Ouerhani S, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, El Gaaied AB. Rouissi K, et al. Among authors: el gaaied ab. Cancer Genet Cytogenet. 2009 Apr 15;190(2):101-7. doi: 10.1016/j.cancergencyto.2009.01.007. Cancer Genet Cytogenet. 2009. PMID: 19380028

2

The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population.

Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M, Hassine LB, Ayed M, Elgaaïed AB. Ouerhani S, et al. Ann Hum Biol. 2006 Sep-Dec;33(5-6):529-35. doi: 10.1080/03014460600907517. Ann Hum Biol. 2006. PMID: 17381051 Free article.

3

Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.

Ouerhani S, Oliveira E, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, El Gaaied AB, Prata MJ. Ouerhani S, et al. Among authors: el gaaied ab. Cancer Genet Cytogenet. 2007 Jul 1;176(1):48-53. doi: 10.1016/j.cancergencyto.2007.03.007. Cancer Genet Cytogenet. 2007. PMID: 17574963

4

The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.

Ouerhani S, Marrakchi R, Bouhaha R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, El Gaaied AB. Ouerhani S, et al. Among authors: el gaaied ab. Bull Cancer. 2008 Feb;95(2):E1-4. doi: 10.1684/bdc.2008.0583. Bull Cancer. 2008. PMID: 18304900

5

Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population.

Ouerhani S, Rouissi K, Marrakchi R, Ben Slama MR, Sfaxi M, Chebil M, ElGaaied AB. Ouerhani S, et al. Cancer Detect Prev. 2009;32(5-6):395-402. doi: 10.1016/j.canep.2009.04.005. Cancer Detect Prev. 2009. PMID: 19588544

6

Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors.

Rouissi K, Stambouli N, Marrakchi R, Slama MR, Cherif M, Sfaxi M, Chebil M, Elgaaied AB, Ouerhani S. Rouissi K, et al. Bull Cancer. 2011 Feb;98(2):E1-10. doi: 10.1684/bdc.2011.1312. Bull Cancer. 2011. PMID: 21339095

7

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.

Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, Hamdi K, Cherif M, Ben Slama MR, Sfaxi M, Othman FB, Chebil M, Elgaaied AB, Ouerhani S. Rouissi K, et al. BMC Cancer. 2011 Mar 22;11:101. doi: 10.1186/1471-2407-11-101. BMC Cancer. 2011. PMID: 21426550 Free PMC article.

8

The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.

Ouerhani S, Elgaaied AB. Ouerhani S, et al. Cancer Biomark. 2011-2012;10(6):259-66. doi: 10.3233/CBM-2012-0254. Cancer Biomark. 2011. PMID: 22820081

9

In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice.

Rouissi K, Hamrita B, Kouidi S, Messai Y, Jaouadi B, Hamden K, Medimegh I, Ouerhani S, Cherif M, Elgaaied AB. Rouissi K, et al. Int J Toxicol. 2011 Aug;30(4):419-27. doi: 10.1177/1091581811410444. Epub 2011 Jul 19. Int J Toxicol. 2011. PMID: 21772021

10

Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.

Marrakchi R, Khadimallah I, Ouerhani S, Gamoudi A, Khomsi F, Bouzaine H, Benamor M, Bougatef K, Mnif S, Zitoun R, Benna F, Boussen H, Rahal K, Elgaaied AB. Marrakchi R, et al. Cancer Invest. 2010 May;28(4):399-407. doi: 10.3109/07357900903405926. Cancer Invest. 2010. PMID: 20014943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters